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Increased susceptibility to co-infection with enteric Gram-negative bacteria, particularly
non-typhoidal Salmonella, is reported in malaria and Oroya fever (Bartonella bacilliformis
infection), and can lead to increased mortality. Accumulating epidemiological evidence
indicates a causal association with risk of bacterial co-infection, rather than just
co-incidence of common risk factors. Both malaria and Oroya fever are characterized
by hemolysis, and observations in humans and animal models suggest that hemolysis
causes the susceptibility to bacterial co-infection. Evidence from animal models
implicates hemolysis in the impairment of a variety of host defensemechanisms, including
macrophage dysfunction, neutrophil dysfunction, and impairment of adaptive immune
responses. One mechanism supported by evidence from animal models and human
data, is the induction of heme oxygenase-1 in bone marrow, which impairs the ability of
developing neutrophils to mount a competent oxidative burst. As a result, dysfunctional
neutrophils become a new niche for replication of intracellular bacteria. Here we critically
appraise and summarize the key evidence for mechanismswhichmay contribute to these
very specific combinations of co-infections, and propose interventions to ameliorate
this risk.
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Introduction
An association between infection-related hemolysis and bacterial co-infection has been known for
almost a century (Giglioli, 1929), but accumulating evidence now shows a clear causal link. Most
of this evidence comes from malaria and non-typhoidal Salmonella (NTS) co-infections (Takem
et al., 2014), but Oroya fever (Bartonella bacilliformis infection) is another hemolytic infection
which is strongly associated with Gram-negative bacterial co-infection (Minnick et al., 2014). In this
review, we outline the causes and consequences of hemolysis, critically appraise the evidence for an
association between infection-related hemolysis and susceptibility to co-infection, and provide an
overview of possible mechanistic explanations.
Hemolysis
Hemolysis is the premature destruction of red blood cells (RBCs) before the end of their normal
life span, and hemolytic anemia occurs when the production of new RBCs from bone marrow
fails to compensate for this loss of RBCs (Guillaud et al., 2012). The causes of hemolysis can be
broadly divided into disorders intrinsic or extrinsic to the RBC, and the location of hemolysis can be
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subdivided into intravascular (within blood vessels) or
extravascular (outside of the blood vessels) (Figure 1). Most
intrinsic RBC defects are hereditary (for example sickle cell
disease, and glucose-6-phosphate dehydrogenase deficiency),
whereas most extrinsic causes are acquired (for example antibody
mediated-hemolysis and malaria) (Guillaud et al., 2012). Most
causes of pathological hemolysis occur in the extravascular
compartment, primarily in the spleen. Macrophages and other
specialized phagocytic cells of the reticuloendothelial system
remove defective RBCs from the circulation. Intravascular
hemolysis follows substantial damage to the RBC membrane.
An important distinction between these processes is the fate of
the RBC contents, particularly the heme moiety of hemoglobin
(Hb) and its iron. Iron is an essential nutrient for pathogen
and host, and access to iron within the body is the focus of an
intense evolutionary battle (Drakesmith and Prentice, 2012;
Barber and Elde, 2014). In extravascular hemolysis RBC contents
become localized within reticuloendothelial cells, whereas in
intravascular hemolysis Hb enters the circulation and can
interact with all molecules and cells in contact with the blood
(Schaer et al., 2013).
Extracellular Hb causes a variety of adverse clinical outcomes,
primarily through NO depletion and free Hb oxidation, which
releases free heme (Omodeo-Sale et al., 2010; Baek et al., 2012;
Schaer et al., 2013). Accumulation of cell-free heme results in
the generation of reactive oxygen species (ROS) and cell damage,
eventually causing chronic inflammation, renal dysfunction and
vascular disease (Belcher et al., 2010; Gladwin et al., 2012; Schaer
et al., 2013). The harmful effects of free heme are abrogated by
multiple layers of defense: first the hemoglobin binding protein,
haptoglobin; second the heme binding protein, hemopexin;
and finally “buffering proteins,” of which the most abundant
is albumin (Gozzelino et al., 2010; Schaer et al., 2013, 2014).
Haptoglobin binds cell-free Hb, preventing release of its heme
moiety, and directing it primarily tomonocytes andmacrophages
expressing CD163 (the haptoglobin receptor) for degradation
(Buehler et al., 2009; Schaer and Alayash, 2010). Haptoglobin
is upregulated in response to systemic inflammation (Schaer
et al., 2014). If levels are depleted by overwhelming hemolysis,
then heme may be liberated from free Hb, and heme binds to
hemopexin, the next line of defense (Schaer et al., 2014). The
hemopexin-heme complex is cleared through receptor-mediated
endocytosis, mainly by macrophages and hepatocytes expressing
the scavenger receptor CD91 (Hvidberg et al., 2005; Schaer
et al., 2014). If the reserve of hemopexin is also overwhelmed,
then albumin and lipoproteins bind relatively weakly to cell-
free heme, offering an additional buffer against its toxicity
(Gozzelino et al., 2010). However, the damaging effects of heme
are not only limited by binding, but also by degradation. Heme
oxygenase-1(HO-1) is an inducible enzyme that catalyzes the
rate-limiting step of heme degradation, converting free heme
into iron, carbon monoxide, and biliverdin (Gozzelino et al.,
2010). HO-1 expression is induced by its substrate, heme, but
also by diverse cytotoxic stimuli, including hypoxia, hyperoxia,
ultraviolet radiation, and inflammation (Ryter et al., 2006). The
degradation of free heme by HO-1 mitigates the harmful pro-
oxidant effects of heme, and the products of heme degradation
have important additional cytoprotective effects, one of the most
important being limitation of the production of ROS (Bilban
et al., 2008; Gozzelino et al., 2010). The many cytoprotective
effects of HO-1 are reviewed elsewhere (Ryter et al., 2006;
Gozzelino et al., 2010), but one important mechanism is the
downstream activation of antioxidant responses, which limit
subsequent intracellular production of ROS (Bilban et al., 2008).
Expression of HO-1 alters many cellular functions and responses,
including responses to inflammatory stimuli and infection (Ryter
et al., 2006; Gozzelino et al., 2010). It is debated whether HO-
1 is anti-inflammatory per se or whether all of its effects can be
explained by its cytoprotective actions (Gozzelino et al., 2010).
Whether hemolysis is intravascular or extravascular, much
of the Hb-derived heme and iron enters macrophages. The
redistribution of the iron from these cells is controlled by
hepcidin (Drakesmith and Prentice, 2012), a protein that controls
the degradation of the iron eﬄux transporter, ferroportin
(Nemeth et al., 2004; Ganz and Nemeth, 2011). Hepcidin is
upregulated in response to infection and inflammation, reducing
iron availability for pathogens in blood and tissues, but resulting
in sequestration of iron within cells of the reticuloendothelial
system, where it may be available to specialized pathogens
(Drakesmith and Prentice, 2012).
Hemolytic Infections
The most important infectious causes of significant hemolysis
are malaria (Cunnington et al., 2012), Bartonellosis (Minnick
et al., 2014), Babesiosis (Gray et al., 2010), and hemolytic
uremic syndrome (Kavanagh et al., 2014), and they differ in
epidemiology, mechanisms and severity of hemolysis. Other
infections may occasionally trigger a secondary autoimmune
hemolysis (Guillaud et al., 2012), but will not be considered in
detail here.
Malaria
Malaria, caused by mosquito-transmitted protozoal parasites of
the genus Plasmodium, is one of the most common infectious
diseases in many tropical countries. There were estimated to be
198 million cases in 2013 (World malaria report, 2015), over 80%
of these in Africa. The erythrocytic phase of the infection results
in repeated cycles of invasion into RBCs, replication within them,
and rupture of RBCs to release daughter parasites. A massive
increase in both intravascular and extravascular hemolysis
occurs, involving both infected and non-infected erythrocytes
(Akinosoglou et al., 2012; Safeukui et al., 2015). The amount of
hemolysis is related to the parasite load (Cunnington et al., 2012),
and is most severe in malaria caused by Plasmodium falciparum.
The spleen is important for removal of parasitized RBCs from
the circulation (Buffet et al., 2009, 2011) and severe anemia
(Hb< 5 g/dL) is relatively common in children in highly endemic
countries (Cunnington et al., 2013a). Malaria causes the release
of Hb into plasma resulting in the formation of Hb-haptoglobin
and heme-hemopexin complexes, internalization into monocytes
and macrophages, and induction of HO-1 (Pamplona et al.,
2007; Ferreira et al., 2008; Yeo et al., 2009; Cunnington et al.,
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FIGURE 1 | Mechanisms and consequences of hemolysis. The fate of
the contents of red blood cells (RBCs) depends on whether hemolysis is
extravascular or intravascular. Following intravascular hemolysis,
hemoglobion (Hb) is bound by haptoglobin and taken up by monocytes
and macrophages. When haptoglobin is depleted, heme is released from
Hb and is bound by hemopexin. The heme-hemopexin complex is primarily
cleared by macrophages and hepatocytes. If hemolysis overwhelms the
capacity of both haptoglobin and hemopexin, heme remains within the
circulation, weakly binding to albumin and lipoproteins, and can interact
with other cell types. In extravascular hemolysis, red blood cells are
removed by phagocytic cells, primarily in the spleen and liver. Heme
released from both intra- and extravascular hemolysis induces the
expression of heme oxygenase-1 (HO-1), which degrades heme to iron,
biliverdin, and carbon monoxide.
2012). Hepcidin is upregulated in malaria, leading to heme
sequestration in macrophages (Drakesmith and Prentice, 2012;
Spottiswoode et al., 2014).
Bartonellosis
Carrion’s disease, caused by the sandfly-transmitted intracellular
bacterium Bartonella bacilliformis, is endemic in the South
American Andes (Minnick et al., 2014). It manifests in two
remarkably different ways, either as a severe systemic bacteremic
illness, Oroya fever, or as a more indolent eruption of blood filled
skin lesions (hemangiomas), verruga peruana. Its epidemiology
is changing, with a 10-fold increase in cases reported in Peru
from 1997 to 2005, and outbreaks occurring in historically
non-endemic regions (Minnick et al., 2014). Oroya fever is
characterized by intense intra-erythrocytic infection and severe
hemolytic anemia (∼80% drop in hematocrit). Few studies
have investigated the mechanisms of hemolysis in Bartonellosis:
increased fragility of red blood cells occurs, but no clear
hemolysin has been identified, and it is likely that hemolysis
is both intra- and extravascular (Reynafarje and Ramos, 1961;
Hendrix, 2000; Minnick et al., 2014).
Babesiosis
Babesiosis is a relatively uncommon tick-borne infectious
disease caused by protozoa of the genus Babesia (most
often Babesia microti). The protozoa invade and replicate
within RBCs, producing an appearance which can be very
similar to malaria on a blood film (Gray et al., 2010).
Most known cases occur in the United States (Centers for
Disease Control Prevention, 2012), but Babesiosis is also an
emerging infection in Europe, China and other countries (Gray
et al., 2010; Hildebrandt et al., 2013; Jiang et al., 2015).
The mechanisms underlying the hemolytic anemia are not
entirely understood, but there is evidence that both intravascular
and extravascular hemolysis occur, with a possible immune-
mediated component (Gray et al., 2010). Severe disease is most
common in the elderly and immunocompromised (including
splenectomised) and whilst anemia is common, severe hemolytic
anemia is relatively rare (White et al., 1998; Gray et al.,
2010).
Hemolytic Uremic Syndrome
Hemolytic uremic syndrome (HUS) is a rare disease, causing
substantial intravascular hemolysis and kidney damage,
secondary to infection with Shiga toxin-producing E. coli and
more rarely Streptococcus pneumoniae (Kavanagh et al., 2014;
Majowicz et al., 2014). Intravascular hemolysis occurs due to
thrombotic microangiopathy, where red blood cells become
fragmented as they pass through small blood vessels (Kavanagh
et al., 2014). Diagnosis of HUS is challenging in resource limited
settings.
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Evidence of a Causal Association with
Co-infections
Co-infections can only occur when the same population is
exposed to both pathogens. Thus, the greatest volume of
evidence for an association between infection-related hemolysis
and bacterial co-infection comes from studies of P. falciparum
malaria and NTS (recently reviewed, Takem et al., 2014), which
are co-endemic in sub-Saharan Africa. Invasive NTS are amongst
the most common bacteria causing invasive disease in children in
sub-Saharan Africa, but are rare community-acquired pathogens
in Europe and North America (Berkley et al., 2005; Feasey
et al., 2012; Ao et al., 2015). Some of the earliest evidence
for a causal association between malaria and NTS infection
comes from deliberate malaria infections (“malariatherapy”).
This was used as a treatment for neurosyphilis before penicillin
was available, and an unusually high incidence of invasive
NTS infection was observed (Hayasaka, 1933). There is a
temporal association of NTS bacteremia with malaria season,
even though NTS fecal carriage remains similar throughout
the year (Mabey et al., 1987), and a decline in the incidence
of NTS has closely mirrored declining malaria transmission
in some countries (Mackenzie et al., 2010; Scott et al., 2011).
The strongest epidemiological evidence of a causal association
comes from a Mendelian randomization study conducted in
Kenya, examining the association between malaria, bacteremia,
and sickle cell trait (SCT, the asymptomatic carrier state of the
sickle cell mutation) (Scott et al., 2011). SCT does not cause
hemolysis, and is known to have a strong protective effect
against malaria. SCT was found to also be protective against
bacteremia with enteric Gram-negative pathogens, conditional
on the incidence of malaria. As malaria incidence declined
over time, the protective effect of SCT against bacteremia was
lost. This study elegantly demonstrated that malaria incidence
explained more than half of all bacteremia in this setting.
Children with severe malarial anemia or very high parasite
load—both indicating the greatest extent of hemolysis—have the
highest risk of bacteremia (Bronzan et al., 2007; Hendriksen
et al., 2013). Consistent with observations in humans, seminal
experimental studies demonstrated increased susceptibility to
Salmonella infection in mice following hemolysis, either through
malaria, chemical or antibody-mediated RBC destruction, but
not anemia from blood-letting (Kaye and Hook, 1963a,b; Kaye
et al., 1965). Later experiments also demonstrated increased
susceptibility to S. enteritidis, Yersinia enterocolitica, and Listeria
monocytogenes associated with hemolysis and specific malaria
species (Murphy, 1981; Roux et al., 2010; Cunnington et al.,
2011).
A link between Bartonellosis and NTS has also been known
for at least 50 years (Cuadra, 1956). In a report of 68 patients
with acute hemolytic Bartonellosis in Peru, 35% had an infectious
complication, with three of the eight positive blood cultures
growing NTS (Maguina et al., 2001). Another observational study
recruited 33 patients with acute Bartonellosis, and of the three
blood culture positive co-infections Salmonella accounted for
two, the other beingKlebsiella (Peregrino et al., 2008).We did not
identify any experimental studies of Bartonellosis with bacterial
co-infection, so causality remains to be proven, despite suggestive
epidemiological evidence.
The relationship between human Babesiosis or hemolytic
uremic syndrome and presdisposition to bacterial co-infections
does not seem to have been investigated. These conditions are
relatively rare and diagnosed most commonly in resource-rich
settings where the incidence of community-acquired bacteremia
is relatively low. However, Babesiosis is an emerging disease in
new geographical regions (Gray et al., 2010; Hildebrandt et al.,
2013; Jiang et al., 2015), raising the possibility of co-infections
occurring in areas where NTS is more common.
Mechanisms of Hemolysis-induced
Susceptibility to Co-infection
Most of the understanding of how hemolysis causes susceptibility
to bacterial infection comes from S. Typhimurium infections in
mice, a model which has underpinnedmost of our understanding
of the pathogenesis of invasive Salmonella infections (Figure 2).
Salmonella initially invade epithelial andM cells of the intestine
within Peyer’s patches (Jones et al., 1994), and bacteria are
then phagocytosed by macrophages and dendritic cells in the
intestinal wall (Mastroeni et al., 2009; Feasey et al., 2012). This
facilitates dissemination via the lymphatic system and blood to
other tissues. In the absence of hemolysis, the spleen and liver
are the major sites of Salmonella replication, where bacteria
are predominately found within macrophages (Richter-Dahlfors
et al., 1997; Salcedo et al., 2001; Mastroeni et al., 2009). The
innate immune response is initially important for control of
bacterial numbers, especially phagocytic cell oxidative burst
activity (Mastroeni et al., 2000; Vazquez-Torres et al., 2000a).
Adaptive immunity, particularly the cell-mediated response,
plays a later role in eventual eradication of bacteria (Feasey
et al., 2012; McSorley, 2014). In the presence of intravascular
hemolysis, bacteria also reach high concentrations in the blood
and are found in large numbers, replicating in a new niche within
neutrophils (Cunnington et al., 2011).
Relatively few unifying mechanisms have been identified to
explain how different causes of hemolysis cause susceptibility
to bacterial co-infection (Figure 2). At the level of invasion
across the intestinal mucosa, one potential mechanism is
hemolysis-related depletion of L-arginine (Chau et al., 2013),
the substrate for nitric oxide synthesis. Arginase, an arginine
degrading enzyme, is released from RBCs during intravascular
hemolysis with free Hb. The latter also drives L-arginine
depletion by scavenging nitric oxide (Kato and Gladwin, 2008).
L-arginine appears important in limiting intestinal permeability
and translocation of both E. coli and NTS (Chau et al., 2013).
Greater interest has focussed on dysfunction of phagocytic
cells—macrophages, and to a lesser extent monocytes and
neutrophils. In extravascular hemolysis, erythrophagocytosis has
relatively little effect on subsequent phagocytosis of bacteria,
but does produce a relatively mild defect in the killing of
Salmonella by macrophages (Hand and King-Thompson, 1983;
Roux et al., 2010). In malarial hemolysis no defect in neutrophil
or monocyte phagocytosis has been observed. However, a
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FIGURE 2 | Mechanisms controlling invasion and dissemination of
non-typhoidal Salmonella (NTS). NTS invades across the intestinal
mucosa, into the submucosal tissues where a local inflammatory cell infiltrate
may limit further invasion. If they evade this response, the bacteria
disseminate through the blood and lymphatics, and reach phagocytic cells in
the spleen and liver, where they may evade killing and replicate. Both
hemolysis in general, and malaria, impair host defense mechanisms at each
stage of NTS infection. Mechanisms which are likely to be general
consequences of intravascular hemolysis are underlined and those that are
likely malaria-specific are not underlined.
defect in neutrophil oxidative burst was found, resulting in
reduced killing of NTS (Cunnington et al., 2011). This is
a particularly compelling explanation for NTS susceptibility,
because Salmonella have evolved a major virulence mechanism
to prevent assembly of the host NADPH oxidase (Vazquez-
Torres et al., 2000b), and the oxidative burst is crucial for
control of infection (Mastroeni et al., 2000; Vazquez-Torres
et al., 2000a). Salmonella show a predilection for invasion of
neutrophils, presumably, because neutrophil killing mechanisms
can be perturbed (Geddes et al., 2007), and accumulation of
Salmonella in neutrophils is a prominent feature of hemolysis-
associated infection (Cunnington et al., 2011). In a mouse
model, impairment of the neutrophil oxidative burst was HO-
1 dependent (Cunnington et al., 2011). Intravascular hemolysis,
due to malaria infection or the chemical hemolytic agent,
phenylhydrazine, reduced oxidative burst activity in neutrophils
during their development in bone marrow. HO-1 induction
occurred in myeloid precursors in bone marrow, and inhibition
of HO-1 abrogated the defect in neutrophil oxidative burst
and restored resistance to S. Typhimurium. This seemingly
elaborate mechanism suggests that susceptibility to co-infection
is the downside of a carefully orchestrated homeostatic response
to limit production of ROS during hemolysis. Free heme
plays a central role in the pathogenesis of experimental severe
malaria infections in mice, by promoting the production of
cytotoxic reactive oxygen species and cell death (Pamplona
et al., 2007; Ferreira et al., 2008; Seixas et al., 2009).
Presumably ROS produced from neutrophils would exacerbate
this toxicity, and reducing production of ROS would be
expected to be beneficial. Impairment of the neutrophil oxidative
burst, related to upregulation of HO-1, has subsequently been
demonstrated in Gambian children with malaria (Cunnington
et al., 2012). Impaired neutrophil oxidative burst has also been
observed in sickle cell disease (Qari and Zaki, 2011), which is
characterized by severe hemolysis and dramatically increased
susceptibility to NTS infection (in contrast to SCT), indicating
this mechanism may be a general consequence of hemolysis.
Several important questions remain unanswered: which heme
containing moiety (and via which receptors) leads to HO-
1 induction during neutrophil development? At which stage
in neutrophil development does this HO-1 induction produce
its effect? And, how exactly does HO-1 induction lead to
suppression of the oxidative burst?
Other mechanisms of susceptibility to co-infection have been
extensively investigated in malaria (Takem et al., 2014). Proposed
mechanisms include impairment of: microvascular blood flow
and gut mucosal barrier function; innate and adaptive intestinal
immunity; antibody production; and splenic, macrophage and
neutrophil function. In P. falciparum malaria, parasitized red
blood cells stick in small blood vessels (Cunnington et al., 2013b)
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in many tissues including the gut, resulting in obstruction,
localized tissue hypoxia and ischemia (White et al., 2013), which
could impair mucosal barrier function (Berkley et al., 2009).
Malaria infection in mice causes IL-10 dependent attenuation of
neutrophil migration into the intestinal mucosa in response to
Salmonella infection, removing another line of defense (Lokken
et al., 2014; Mooney et al., 2014). Macrophage dysfunction
occurs secondary to ingestion of hemozoin, the insoluble hemin
polymer generated by parasites during hemoglobin digestion
(Boura et al., 2013), inhibiting oxidative burst activity, expression
of MHC-class-II, phagocytosis and killing of bacteria (Schwarzer
et al., 1992, 1998; Schwarzer and Arese, 1996), and IL-12
secretion (Keller et al., 2006). IL-12 is important in control of
Th1 responses and reduced expression increases susceptibility
to Salmonella (MacLennan et al., 2004). Malaria suppresses
heterologous antibody responses (Cunnington and Riley, 2010),
and antibodies are an important component of defense against
NTS (MacLennan et al., 2008; Gondwe et al., 2010). Alterations
in spleen function and accumulation of iron in macrophages
may also be important (van Santen et al., 2013; Gomez-Perez
et al., 2014). To our knowledge mechanisms for the increased
susceptibility to co-infection in Bartonellosis have not been
investigated. Of the proposed mechanisms above, we believe
that HO-1 dependent neutrophil dysfunction provides the most
plausible explanation for susceptibility to co-infection occurring
during hemolysis in malaria, Oroya fever and non-infectious
causes in experimental models.
Prevention of Co-infection and
Co-morbidity
Malaria and Bartonellosis can be diagnosed rapidly where
appropriate resources exist (Minnick et al., 2014; World malaria
report, 2015) but diagnosis of bacterial co-infection is more
difficult, both clinically (because the pre-existing infection
may mask signs and symptoms of secondary infection) and
in the laboratory (because blood cultures are required, with a
24–48 h incubation period) (Takem et al., 2014). Identification
of markers to stratify risk of co-infection could allow those
at highest risk to receive empirical antibiotic prophylaxis or
treatment. Quantitative measurement of P. falciparum histidine
rich protein 2 (PfHRP2), is a promising marker to identify those
with malaria at risk of co-infection (Hendriksen et al., 2013).
Another strategy would be to modulate HO-1 activity, since
tin protoporphyrin can reverse HO-1–mediated neutrophil
dysfunction (Cunnington et al., 2011), but only after treatment
of the hemolytic infection in order to avoid exacerbated heme
toxicity. The greatest reduction in co-morbidity will undoubtedly
come from public health measures to control or eliminate the
hemolytic infections. Malaria control is already known to
produce dramatic decreases in the population burden of NTS
bacteremia (Mackenzie et al., 2010; Scott et al., 2011) and
all-cause child mortality (Kleinschmidt et al., 2009). Control of
Carrion’s disease appears more challenging, and indications of
expanding geographical distribution suggest that co-infections
may remain a problem for the foreseeable future (Minnick et al.,
2014).
Conclusion
A causal link between infection-related hemolysis and bacterial
co-infection has been established for the association of malaria
and NTS. Further research is needed to confirm whether the
same mechanism applies in Oroya fever, and whether Babesiosis
will predispose to co-infection in the same way. This may also
give us greater insight into bacterial infections occurring in
non-infectious hemolytic diseases, such as sickle cell disease.
Although infection prevention is likely to have the biggest
impact on mortality, a greater mechanistic understanding may
allow targeted interventions to those most at risk of bacterial
co-infection.
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